Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Control Intervention1: HEPARIN SODIUM: DRUG:TOPICAL HEPARIN SODIUM 1000 IU/ml solution
DOSE & SITE: 8 drops at the surrounding area of peripheral intravenous catheter site.
FREQUENCY: from time of i
Sponsors
PARUL INSTITUTE OF MEDICAL SCIENCE AND RESEARCH
Eligibility
Inclusion criteria
Inclusion criteria: Planned to undergo peripheral vein cannulation that has been planned to remain in situ for at least 48 hours of indoor period
Exclusion criteria
Exclusion criteria: 1.Undergoing re-cannulation due to phlebitis at earlier cannulation site 2.Unconscious or comatose patients 3.History of hypersensitivity reaction to heparin or heparin induced thrombocytopenia 4. Signs of systemic infection, bacteremia 5. Planned administration of any of the following during study period: 5.1 Anti-coagulants locally (in the cannula) or systemically. 5.2 NSAIDs locally over surrounding area 6. Participated in any clinical trial within last 30 days at the time of screening. 7. Any disorder or condition that in the opinion of investigator would prohibit study participation or affect study outcome.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NO OCCURRENCE OF THROMBOPHLEBITIS IN CASES WHERE PROPHYLACTIC TOPICAL HEPARIN APPLIEDTimepoint: 48 HOURS | — |
Secondary
| Measure | Time frame |
|---|---|
| any adverse effect noted after application of topical heparin solutionTimepoint: 48 hours | — |
Countries
India
Contacts
Public ContactDR JAIMIN PANDYA
PARUL INSTITUTE OF MEDICAL SCIENCE AND RESEARCH
Outcome results
None listed